RC: 1892044

Nexa Pharmaceuticals Ltd.

A fully licensed Nigerian pharmaceutical brand built for regulated scale.

The "Killer Stat" Overlay: This entity holds the exclusive legal right to generate and sell power to [Target Area], a captive market of 50,000 paying users, with zero grid competition.

Status: Available Sector: Pharmaceuticals Foreign-Owned Eligible
Schedule Due Diligence Call Request Acquisition Brief (NDA Required)
Incorporation Fully Registered
Regulatory Status Compliant (NAFDAC)
Banking Bank-Ready Structure
Ownership Attorney-Managed Transfer

The Brand Thesis

Nigeria’s pharmaceutical sector suffers from fragmented compliance, undercapitalized operators, and regulatory inconsistency.

This brand was engineered to reverse that reality — with institutional-grade structure, export readiness, and a compliance-first operating model.

Rather than retrofitting legacy inefficiencies, the company was built from inception to scale under foreign ownership.

Brand Asset

Acquisition Readiness Index™

A real-time assessment of operational, legal, and execution readiness — built for foreign acquisition and immediate control.

92 /100

Acquisition-Ready

Legal & Corporate Structure

100%

Clean incorporation. Attorney-managed ownership transfer.

Regulatory & Compliance

95%

Sector approvals mapped, verified, and documented.

Banking & Financial Control

90%

Bank-ready structure with signatory transfer pathway.

Operational Execution

88%

Execution frameworks independent of founders.

Brand & Market Positioning

95%

Institutional-grade brand, export-ready narrative.

What This Score Represents

This index reflects the company’s present-day readiness for acquisition, ownership transfer, and operational launch — not projected growth or valuation.

Why It Matters for Non-Resident Buyers

Execution risk exceeds market risk for foreign operators. This score exists to eliminate ambiguity before capital is deployed.